Literature DB >> 7771606

National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome.

M J Dalton1, M J Clarke, R C Holman, J W Krebs, D B Fishbein, J G Olson, J E Childs.   

Abstract

Between 1981 and 1992, the Centers for Disease Control collected and summarized 9,223 cases of Rocky Mountain spotted fever (RMSF) reported from 46 states. Four states (North Carolina, Oklahoma, Tennessee, and South Carolina) accounted for 48% of the reports. The annual incidence per million U.S. population decreased from a high in 1981 of 5.2 to a low in 1992 of 2.0, primarily due to decreased incidence in the southeast. Case report forms were filed on 7,650 patients, of whom 4,217 had laboratory-confirmed RMSF. The age group with the highest incidence was those 5-9 years of age. Most cases (90.0%) occurred between April 1 and September 30 and included a history of tick attachment (59.6%). Reported symptoms included fever (94.0%), headache (86.2%), myalgia (82.5%), and rash (80.2%). The case-fatality ratio was 4.0%. Risk factors associated with death included older age, delay in treatment or no treatment, and treatment with chloramphenicol (compared with tetracycline); however, insufficient data existed to fully assess the confounding effect of severity of illness on antibiotic choice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771606     DOI: 10.4269/ajtmh.1995.52.405

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

Review 1.  Clinical manifestations of tick-borne infections in children.

Authors:  K A Bryant; G S Marshall
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.

Authors:  Sean P Riley; Kenneth C Goh; Timothy M Hermanas; Marissa M Cardwell; Yvonne G Y Chan; Juan J Martinez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

3.  Analysis of fluorescent protein expression in transformants of Rickettsia monacensis, an obligate intracellular tick symbiont.

Authors:  Gerald D Baldridge; Nicole Burkhardt; Michael J Herron; Timothy J Kurtti; Ulrike G Munderloh
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

4.  Phylogeography of Rickettsia rickettsii genotypes associated with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Amy M Denison; R Ryan Lash; Lindy Liu; Brigid C Bollweg; F Scott Dahlgren; Cristina T Kanamura; Rodrigo N Angerami; Fabiana C Pereira dos Santos; Roosecelis Brasil Martines; Sandor E Karpathy
Journal:  Am J Trop Med Hyg       Date:  2014-06-23       Impact factor: 2.345

5.  Lethal effect of Rickettsia rickettsii on its tick vector (Dermacentor andersoni).

Authors:  M L Niebylski; M G Peacock; T G Schwan
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

6.  Knowledge, attitudes, and practices regarding Rocky Mountain spotted fever among healthcare providers, Tennessee, 2009.

Authors:  Emily Mosites; L Rand Carpenter; Kristina McElroy; Mary J Lancaster; Tue H Ngo; Jennifer McQuiston; Caleb Wiedeman; John R Dunn
Journal:  Am J Trop Med Hyg       Date:  2012-12-12       Impact factor: 2.345

7.  Incidence of Rocky Mountain spotted fever among American Indians in Oklahoma.

Authors:  J H McQuiston; R C Holman; A V Groom; S F Kaufman; J E Cheek; J E Childs
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

8.  Rocky Mountain Spotted Fever and Pregnancy: Four Cases from Sonora, Mexico.

Authors:  Jesus David Licona-Enriquez; Jesus Delgado-de la Mora; Christopher D Paddock; Carlos Arturo Ramirez-Rodriguez; María Del Carmen Candia-Plata; Gerardo Álvarez Hernández
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

9.  Pathogenic Rickettsia species acquire vitronectin from human serum to promote resistance to complement-mediated killing.

Authors:  Sean P Riley; Jennifer L Patterson; Samantha Nava; Juan J Martinez
Journal:  Cell Microbiol       Date:  2013-12-13       Impact factor: 3.715

Review 10.  The human ehrlichioses in the United States.

Authors:  J H McQuiston; C D Paddock; R C Holman; J E Childs
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.